AXR 📈 AMREP - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0321591051
AXR: Land, Lots, Homes, Development, Construction, Real Estate
AMREP Corporation, through its subsidiaries, engages in the real estate business in the United States. It operates through two segments, Land Development and Homebuilding. The company markets and sells developed and undeveloped lots to homebuilders, commercial, and industrial property developers through brokers. It also offers various services comprising land and site planning, obtaining of governmental and environmental approvals, installation of utilities and storm drains, ensuring availability of water services, building or improving of roads for land development services, and construction of community amenities; and landscaping services to homebuilders. In addition, the company operates as a homebuilder; and sells single-family detached homes and attached homes. AMREP Corporation was founded in 1961 and is headquartered in Havertown, Pennsylvania. Web URL: https://amrepcorp.com
Additional Sources for AXR Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AXR Stock Overview
Market Cap in USD | 203m |
Sector | Real Estate |
Industry | Real Estate - Development |
GiC Sub-Industry | Diversified Support Services |
IPO / Inception | 1973-05-03 |
AXR Stock Ratings
Growth 5y | 90.8% |
Fundamental | 43.5% |
Dividend | 3.16% |
Rel. Strength Industry | 123 |
Analysts | - |
Fair Price Momentum | 39.80 USD |
Fair Price DCF | 93.59 USD |
AXR Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 10.5% |
AXR Growth Ratios
Growth Correlation 3m | 78.8% |
Growth Correlation 12m | 64.5% |
Growth Correlation 5y | 90.4% |
CAGR 5y | 41.11% |
CAGR/Mean DD 5y | 2.40 |
Sharpe Ratio 12m | 0.89 |
Alpha | 34.75 |
Beta | 0.35 |
Volatility | 91.62% |
Current Volume | 78.8k |
Average Volume 20d | 34.9k |
What is the price of AXR stocks?
As of December 22, 2024, the stock is trading at USD 31.91 with a total of 78,809 shares traded.
Over the past week, the price has changed by -12.38%, over one month by -16.40%, over three months by +6.51% and over the past year by +47.39%.
As of December 22, 2024, the stock is trading at USD 31.91 with a total of 78,809 shares traded.
Over the past week, the price has changed by -12.38%, over one month by -16.40%, over three months by +6.51% and over the past year by +47.39%.
Is AMREP a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, AMREP (NYSE:AXR) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AXR as of December 2024 is 39.80. This means that AXR is currently undervalued and has a potential upside of +24.73% (Margin of Safety).
Partly, yes. Based on ValueRay Fundamental Analyses, AMREP (NYSE:AXR) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AXR as of December 2024 is 39.80. This means that AXR is currently undervalued and has a potential upside of +24.73% (Margin of Safety).
Is AXR a buy, sell or hold?
AMREP has no consensus analysts rating.
AMREP has no consensus analysts rating.
What are the forecast for AXR stock price target?
According to ValueRays Forecast Model, AXR AMREP will be worth about 43.3 in December 2025. The stock is currently trading at 31.91. This means that the stock has a potential upside of +35.79%.
According to ValueRays Forecast Model, AXR AMREP will be worth about 43.3 in December 2025. The stock is currently trading at 31.91. This means that the stock has a potential upside of +35.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 2.5 | -92.3% |
Analysts Target Price | 2.5 | -92.3% |
ValueRay Target Price | 43.3 | 35.8% |